Gilead Sciences

Vertex Pharmaceuticals

Amgen

Regeneron Pharmaceuticals

IQVIA Hlds

Alnylam Pharmaceuticals

Mettler-Toledo

Biogen

Illumina

Waters

iShares Nasdaq Biotechnology ETF

IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges.

Catalyst Pharmaceuticals

Inspire Medical Systems Inc

Novocure

Revance Therapeutics

Teva Pharmaceutical

Zai Lab Ltd.

Biotech and medical device stocks can be highly profitable. One of these volatile issues just catapulted over 41%.

Biotech Stocks Reward Shareholders Who Handle The Bumpy Ride

SPDR S&P Biotech ETF

Pharma and biotech stocks moved in opposite directions last year, but fortunes are shifting.

Why Biotech Is Poised for a Recovery This Year

Prometheus Biosciences

SAGE Therapeutics

In a strong week for the market, biotech dominated. Today we will cover 3 promising stocks in the space.

Biotech's Blockbuster Week: 3 Stocks to Watch

iShares Biotechnology has outperformed the S&P 500 during all 3 recessions in the U.S. since inception in early 2001. Healthcare and pharmaceutical shares have a strong track record of holding up during bear markets and recessions over the last 100 years.

IBB: A History Of Outperformance During Recessions

Global X Longevity Thematic ETF 

ARK Genomic Revolution Multi-Sector ETF

Virtus LifeSci Biotech Clinical Trials ETF

VanEck Vectors Biotech ETF

Virtus LifeSci Biotech Products ETF

BlackRock Future Health ETF

Principal Healthcare Innovators Index ETF

Loncar Cancer Immunotherapy ETF

Global X Telemedicine & Digital Health ETF

First Trust NYSE Arca Biotechnology Index Fund

Fidelity MSCI Health Care ETF

First Trust Nasdaq Pharmaceuticals ETF 

First Trust Health Care AlphaDEX Fund

Amplify Treatments Testing & Advancements ETF

Global X Genomics & Biotechnology ETF

 Franklin Genomic Advancements ETF

ROBO Global Healthcare Technology and Innovation ETF

Invesco Nasdaq Biotechnology ETF

iShares Genomics Immunology and Healthcare ETF

iShares U.S. Pharmaceuticals ETF

iShares U.S. Healthcare Providers ETF

iShares U.S. Medical Devices ETF

iShares Global Healthcare ETF

iShares U.S. Healthcare ETF

Eli Lilly

Global X Longevity Thematic ETF

First Trust Indxx Medical Devices ETF

Merck

Novo Nordisk

Invesco Dynamic Biotechnology & Genome ETF

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Simplify Health Care ETF

Invesco Dynamic Pharmaceuticals ETF

VanEck Vectors Pharmaceutical ETF

Invesco S&P SmallCap Health Care ETF

Invesco DWA Healthcare Momentum ETF

Invesco S&P 500 Equal Weight Health Care ETF

ALPS Medical Breakthroughs ETF

Vanguard Health Care ETF

Wisdomtree BioRevolution Fund

SPDR S&P Health Care Equipment ETF

SPDR S&P Health Care Services ETF

Health Care Select Sector SPDR Fund

SPDR S&P Pharmaceuticals ETF

How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

Can Health Care Stocks Outperform Again In 2023?

Subversive Decarbonization ETF

Subversive Food Security ETF

Subversive Mental Health ETF

The debut highlights the lack of funds focused on the area.

Subversive Launches ETF to Focus on Mental Health

Fidelity MSCI Materials Index ETF

iShares U.S. Industrials ETF

Vanguard Energy ETF

SPDR S&P Oil & Gas Equipment & Services ETF

Materials Select Sector SPDR Fund

Industrial Select Sector SPDR Fund

These four top-ranked sector ETFs topped the market in the ongoing fourth quarter.

4 Market-Beating Top Sector ETFs of Q4 to Buy Now

Biotech stocks, while a volatile spot of the broad U.S. market, look good from a risk/reward point of view. IBB's valuation is reasonable relative to history while the technical chart sports a bullish breakout.

IBB: Shares Breaking Out With A Still-Reasonable Valuation

iShares Core S&P Small Cap ETF

Energy Select Sector SPDR Fund

Albion Financial's Jason Ware sees funds as mainstays in ‘core-satellite' planning.

ETFs Find a Role in a Long-Term Portfolio

Biotech earnings have come in upbeat in the third quarter.

How Are Biotech ETFs Reacting to Q3 Earnings Releases?

Biotech will continue to outperform the benchmark since the U.S. economy is currently in late-cycle expansion, says Bryn Talkington. She's a Managing Partner at Requisite Capital Management.

XBI vs IBB: what's a better way to play the biotech space?

Akero Therapeutics Inc

bluebird bio

Chemocentryx

Forma Therapeutics Holdings

Karuna Therapeutics Inc

Pfizer

Rhythm Pharmaceuticals

Biotechs are relatively better positioned in this fourth quarter compared to the broader market. Path of interest rates is clearer for 2022 and the Fed is closer to a pause early next year as it calibrates down its response from a hammer approach.

Biotech Stocks Well-Positioned For Fourth Quarter

Assertio Therapeutics Inc

Magellan Midstream Partners

Altria

Rio Tinto plc Sponsored

Tyson Foods

Vanguard Value ETF

These are seven of the best stocks to buy that can see substantial returns in the months ahead. Despite the ongoing worries on Wall Street, seasoned investors realize that there may be a bull market in some segments of the market even during these gloomy weeks.

The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market

The market has turned for the worst in recent weeks and continues to fall in a bear market fashion.  Most of our portfolio strategies are holding more than 50% cash, some are utilizing inverse ETFs, and in my discretionary trading service, we are largely in cash.

Why the Biotech Sector Should Come Back First

IBB ETF has rarely been this oversold. Volume, AUM growth and reducing short interest all point to higher prices in the IBB fund.

IBB ETF: On Sale And Rich Option Premium To Boot

CRISPR Therapeutics

Exelixis

Ionis Pharma

Twist Bioscience Corp

I've written before about how biotech is the biggest technology trend of our kids' generation. Naturally, that means many people are looking for the best biotech stocks to buy.

The 7 Best Biotech Stocks to Buy

Invesco Dow Jones Industrial Average Dividend ETF

Mirati Therapeutics

Cancer-drug maker Amgen solidified its position in a highly competitive market by acquiring its rival Mirati Therapeutics.

Cancer-Drug Maker's Solid Position And Successful Drug Record Drive Growth

iShares Russell 2000 ETF

iShares Transportation Average ETF

VanEck Vectors Semiconductor ETF

SPDR S&P Retail ETF

Semiconductors have been a significant drag on Wall Street. Sister Semiconductors (SMH) needs to regain her -50week moving average to really see a major technical shift in the market.

Key Economic ETFs Reveals All for Investors

The ALPS Medical Breakthroughs ETF (SBIO) was ALPS' top-performing ETF in August, propelled by positive earnings and M&A announcements in the portfolio.   SBIO increased 8.65% on a total return basis between August 1 and August 31.

SBIO Was ALPS' Top Performing ETF in August

ProShares Ultra Nasdaq Biotechnology

iShares Neuroscience And Healthcare ETF

Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus to neurological health. Recent advances in genomics and immunology, new diagnostics and surgeries, and reductions in stigma associated with mental health are unlocking radical progress in neuroscience this decade akin to the genomics revolution of the past two decades.

Why Now Could Be The Time To Consider Neuroscience Investments

The recently enacted Inflation Reduction Act looks to rein in prescription drug prices and could impact the pharma industry's long-term financial performance. The legislation caps out-of-pocket costs for Medicare prescriptions at $2,000 per year, starting in 2025.

What The Inflation Reduction Act Means For Drug Prices

Biotechnology sector-related exchange traded funds are making a swift rebound as a spate of dealing making and new drug approvals helped reinvigorate the segment. For instance, the SPDR S&P Biotech ETF (XBI), which follows a more equal-weight indexing methodology that provides greater emphasis on mid-sized companies, increased 41.

Biotech ETFs Are on the Mend

he Biotech sector has been in a sweet spot for quite some time now. Plus, earnings releases have also come in mostly upbeat.

How Are Biotech ETFs Reacting to Q2 Earnings Releases?

The Nasdaq Biotechnology ETF is a long-term outperformer but in the last years it lagged it peers. In the last weeks, this industry showed relative strength to the market and a comeback is probable.

IBB: Biotechnology Offers A Compelling Opportunity As It Builds Up Momentum

Today's reaction to a high CPI print is the opposite of what we saw last month.

The Overlooked Difference in June's Inflation Report

News for iShares Nasdaq Biotechnology ETF ETF (IBB)